Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-017754
Filing Date
2024-02-28
Accepted
2024-02-28 08:08:13
Documents
13
Period of Report
2024-02-28

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0200856-6k_immuron.htm 6-K 12568
2 APPENDIX 4D AND HALF YEAR REPORT ea0200856ex99-1_immuron.htm EX-99.1 465992
3 GRAPHIC image_001.jpg GRAPHIC 1254
4 GRAPHIC ex99-1_001.jpg GRAPHIC 211078
5 GRAPHIC ex99-1_002.jpg GRAPHIC 213254
6 GRAPHIC ex99-1_003.jpg GRAPHIC 2903
7 GRAPHIC ex99-1_004.jpg GRAPHIC 217988
8 GRAPHIC ex99-1_005.jpg GRAPHIC 238076
9 GRAPHIC ex99-1_006.jpg GRAPHIC 222424
10 GRAPHIC ex99-1_007.jpg GRAPHIC 4733
11 GRAPHIC ex99-1_008.jpg GRAPHIC 2275
12 GRAPHIC ex99-1_009.jpg GRAPHIC 2021
13 GRAPHIC ex99-1_010.jpg GRAPHIC 2406
  Complete submission text file 0001213900-24-017754.txt   2021629
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 24690271
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)